Perceptive Advisors - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$75,818,568
-20.4%
11,350,0850.0%2.53%
-8.2%
Q2 2023$95,227,213
-15.5%
11,350,0850.0%2.76%
-17.2%
Q1 2023$112,706,344
+42.7%
11,350,0850.0%3.33%
+50.0%
Q4 2022$78,996,592
+30.3%
11,350,0850.0%2.22%
+26.1%
Q3 2022$60,609,000
+53.4%
11,350,085
+14.6%
1.76%
+42.1%
Q2 2022$39,516,000
-10.2%
9,903,8790.0%1.24%
+40.4%
Q1 2022$44,023,000
-44.4%
9,903,879
-50.0%
0.88%
+44.4%
Q4 2021$79,232,000
-8.9%
19,807,758
+100.0%
0.61%
-51.6%
Q3 2021$86,956,000
-61.3%
9,903,879
-50.0%
1.26%
-13.4%
Q2 2021$224,422,000
+117.0%
19,807,758
+127.6%
1.46%
+11.5%
Q1 2021$103,402,000
+139.8%
8,703,879
+38.5%
1.31%
+182.5%
Q4 2020$43,118,000
-7.4%
6,285,4580.0%0.46%
-31.9%
Q3 2020$46,575,000
+262.0%
6,285,458
+103.7%
0.68%
+226.9%
Q2 2020$12,866,000
+68.8%
3,085,4580.0%0.21%
+5.1%
Q1 2020$7,621,000
-57.5%
3,085,4580.0%0.20%
-44.4%
Q4 2019$17,926,000
+10.2%
3,085,4580.0%0.36%
-18.7%
Q3 2019$16,260,000
-12.2%
3,085,4580.0%0.44%
+3.1%
Q2 2019$18,512,000
-33.6%
3,085,4580.0%0.42%
-45.9%
Q1 2019$27,862,000
+12.9%
3,085,4580.0%0.79%
-16.3%
Q4 2018$24,684,000
-42.0%
3,085,4580.0%0.94%
-17.6%
Q3 2018$42,579,000
+73.6%
3,085,4580.0%1.14%
+77.1%
Q2 2018$24,529,000
+6.0%
3,085,4580.0%0.64%
-0.8%
Q1 2018$23,141,000
+10.3%
3,085,4580.0%0.65%
-6.8%
Q4 2017$20,981,000
-52.8%
3,085,458
-50.0%
0.70%
-18.0%
Q3 2017$44,430,000
+231.1%
6,170,916
+113.9%
0.85%
+25.6%
Q2 2017$13,417,000
+4.0%
2,885,4580.0%0.68%
-8.2%
Q1 2017$12,897,000
+24.2%
2,885,458
+48.7%
0.74%
-0.4%
Q4 2016$10,381,000
-31.6%
1,940,4580.0%0.74%
-24.6%
Q3 2016$15,174,000
+37.4%
1,940,4580.0%0.98%
+28.0%
Q2 2016$11,041,000
+112.4%
1,940,458
+56.4%
0.76%
+67.8%
Q1 2016$5,197,000
-38.2%
1,240,4580.0%0.46%
-26.7%
Q4 2015$8,410,000
-24.6%
1,240,458
-35.2%
0.62%
+39.5%
Q3 2015$11,160,000
+65.4%
1,914,386
+120.1%
0.45%
+9.9%
Q2 2015$6,749,000
+85.7%
869,800
+143.6%
0.41%
+44.0%
Q1 2015$3,634,000357,0000.28%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,031,915$20,253,19221.02%
Perceptive Advisors 11,350,085$75,818,5682.53%
JOHNSON & JOHNSON 394,834$2,637,4910.97%
Joseph P. Lucia & Associates, LLC 28,331$189,2510.13%
WOODSTOCK CORP 137,179$916,3560.12%
Palo Alto Investors LP 160,800$1,074,1440.10%
Affinity Asset Advisors, LLC 44,348$296,2450.08%
Verition Fund Management LLC 935,273$6,247,6240.07%
FOX RUN MANAGEMENT, L.L.C. 33,519$223,9070.07%
TOBIAS FINANCIAL ADVISORS, INC. 34,173$228,2760.06%
View complete list of ALDEYRA THERAPEUTICS INC shareholders